Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
David Verga

Email: media@path.org

PATH is advancing health equity around the world

June 7, 2024
Medical oxygen in the spotlight: What can be done to improve access for good?
May 30, 2024
A day with co-creators exhibiting inclusive innovation in Kenya
May 29, 2024
Lessons from Malawi's collaborative approach to digital health

Stay informed with PATH Insights

Featured Press Coverage

February 8, 2024
Good intentions, bad outcomes: The dangers of donated medical devices
Devex
April 18, 2024
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The New York Times
February 12, 2024
Could new vaccines end malaria in Africa?
Al Jazeera

Recent Press Coverage

  1. Opinion: GenAI for global health — the bear and the bull case
    Dr. Bilal Mateen, PATH’s Chief AI Officer, highlights GenAI’s potential in diagnostics, disease surveillance, and health communication while addressing challenges like data privacy and equity.
    Published: December 2024
  2. Life-saving advances in vaccines pave the way for healthier futures
    Dr. Cathy Ndiaye, Director of HPV Vaccine Programs at PATH, shares her personal connection to the fight against cervical cancer and her efforts to address disparities in prevention and care.
    Published: November 2024
  3. Why global health organizations are hiring chief AI officers
    Nikolaj Gilbert, President and CEO of PATH, shares insights on the growing trend of global health organizations appointing Chief AI Officers (CAIOs) to harness the transformative potential of artificial intelligence in healthcare.
    Published: September 2024
  4. The first vaccine for malaria received major regulatory approval in 2015.
    The first vaccine for malaria received major regulatory approval in 2015. It didn’t become part of vaccination programs in Africa until 2024. PATH's Ashley Birkett speaks about the manufacturing plans that GSK had put in place were derailed.
    Published: July 2024
Next

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

972 Item s
972 Item s
    Date
    From
    To
  1. PATH selected as health information systems lead in Africa CDC mpox initiative
    The Africa Centres for Disease Control and Prevention has selected PATH to partner on health information systems as part of its continental response to mpox.
    Published: December 2024
    Announcement
  2. PATH and partners receive award for novel oral polio vaccine type 2 (nOPV2) project
    With more than a billion doses delivered so far, this next-generation oral polio vaccine is accelerating progress toward polio eradication.
    Published: December 2024
    Announcement
  3. PATH as a major sub-partner for USAID-funded STRIDES Activity
    PATH, as a major sub-partner on the consortium led by FHI360, launches the STRengthening Infectious disease DEtection Systems (STRIDES) Activity: a new Activity funded by USAID to combat epidemics, pandemics, and novel infectious disease threats.
    Published: November 2024
    Press Release
  4. PATH and Bio-Manguinhos/Fiocruz commit to boosting technological platforms and increasing local production
    Published: October 2024
    Announcement
  5. PATH shares topline results from a Phase 3 study of an injectable rotavirus vaccine candidate
    The trial aimed to determine how well a new, injectable, non-replicating rotavirus vaccine candidate works, compared to a licensed oral rotavirus vaccine in preventing infant diarrhea.
    Published: October 2024
    Announcement
Next